NimaGen

Company Details

Website LinkedIn

Status: Private

Employees: 11-50

Location:

Nijmegen, Netherlands

Type:

sample

Technology:

sample

About: - Our DNA - NimaGen, part of the Dutch Biolegio Holding and founded in 2011, is a well-recognized ISO certified manufacturer and vendor of reagents and workflow solutions for Sanger Sequencing and Next Generation Sequencing (NGS). We serve molecular biology laboratories around the world, active in human genetics, forensics, microbiology and infectious disease. - Our Mission - NimaGen’s mission is helping laboratories create value for their customers, through proven and cost-effective workflows, providing detailed insights and enabling informed decision making. From clinical research to forensics to agriculture to food safety and environmental hygiene. - Patented Core Technology - Our core technology, Reverse Complement PCR (RC-PCR), provides the most safe, swift and simple worklow for NGS Library Prep. It comprises simultaneous multiplex target amplification and NGS indexing or barcoding in a single, closed tube PCR assay. Compatible with illumina® and Oxford Nanopore Technologies®. - Sanger Sequencing Workflow Reagents - We are the globally recognized provider of a complete workflow portfolio of drop-in reagents for 3130, 3500, 3730 and SeqStudio™ Genetic Analyzers. From PCR purification to dyeterminator reaction cleanup and running samples, to safeguarding capillary operational life span. For DNA sequencing results and data you can trust. - Featured Brands - EasySeq™, IDseek®, BrilliantDye™, NimaPOP™, NimaPrime™, D-Pure™, iX-Pure™, ExS-Pure™, Alpaqua®, AmpliClean™, Biolegio. - Further Information - Please contact NimaGen’s resourceful specialists: • E-mail: info@nimagen.com • Website: www.nimagen.com; www.rcpcr.com • Instagram: @nimagen; LinkedIn: @NimaGen

Unlock access to company contacts, hot leads, and drug pipelines.

NimaGen | Active clinical trials on ClinicalTrials.gov

Active Clinical Trials Count | 0

No Active Trials Found On ClinicalTrials.gov.